Jasim Shaymaa Kadhim, Al-Momen Hayder, Mahdi Zina Ismaiel, Almomen Rand
Department of Obstetrics and Gynecology, University of Baghdad, College of Medicine, Baghdad, Iraq
Department of Pediatrics, University of Baghdad, Al-Kindy College of Medicine, Baghdad, Iraq
J Turk Ger Gynecol Assoc. 2023 Mar 15;24(1):12-17. doi: 10.4274/jtgga.galenos.2022.2021-10-6.
Gestational diabetes (GDM) is increasing in prevalence with effects starting in-utero, leading to excessive fetal growth. It is the leading cause of many perinatal complications. The aim was to determine the rate of obstetric and neonatal complications in pregnant women with high fetal weight and a recent diagnosis of GDM during the third trimester, despite normal earlier glycemic control.
Prospective cohort study over four years involving pregnant women regularly visiting a single center who had normal glycemic index at 24-28 gestational weeks and ultrasonography (US) suggested high fetal weight during the third trimester. Oral glucose tolerance test was given, dividing the sample into the late GDM (LGDM) and the non-LGDM group.
Of 176 women, 24 (13.64%) had LGDM, and 152 (86.36%) had non-LGDM. After exclusions these groups' sizes were (n=21) in LGDM and (n=132) in non-LGDM. Hemoglobin A1c level was significantly higher in LGDM than non-LGDM (5.9% versus 5.1%). However, obstetric and neonatal complications were largely comparable (p≥0.05) but higher in LGDM than non-LGDM women. Exceptions to this were birth weight (3219 g versus 3326 g), large for gestational age at delivery (85.72% versus 88.64%), and gestational age at delivery (37.9 versus 38.2 weeks) in the LGDM vs. non-LGDM groups, respectively. There was a significantly higher cesarean section (CS) rate (76.19% versus 51.52%; p<0.05) in the LGDM group.
The rate of newly diagnosed LGDM in pregnant women with high fetal weight during the third trimester by US was 13.64%. They had comparable obstetric and neonatal complications with non-GDM women, except for the rate of CS that was significantly higher in LGDM women.
妊娠期糖尿病(GDM)的患病率正在上升,其影响始于子宫内,可导致胎儿过度生长。它是许多围产期并发症的主要原因。本研究旨在确定孕晚期胎儿体重高且近期诊断为GDM的孕妇,尽管早期血糖控制正常,但产科和新生儿并发症的发生率。
一项为期四年的前瞻性队列研究,纳入了定期到单一中心就诊的孕妇,这些孕妇在孕24 - 28周时血糖指数正常,且超声检查(US)提示孕晚期胎儿体重高。进行口服葡萄糖耐量试验,将样本分为晚发型GDM(LGDM)组和非LGDM组。
176名女性中,24名(13.64%)患有LGDM,152名(86.36%)患有非LGDM。排除后,LGDM组有21名,非LGDM组有132名。LGDM组糖化血红蛋白水平显著高于非LGDM组(5.9%对5.1%)。然而,产科和新生儿并发症在很大程度上具有可比性(p≥0.05),但LGDM组高于非LGDM组女性。LGDM组与非LGDM组在出生体重(3219克对3326克)、出生时大于胎龄儿(85.72%对88.64%)以及分娩孕周(37.9周对38.2周)方面存在差异。LGDM组剖宫产(CS)率显著更高(76.19%对51.52%;p<0.05)。
超声提示孕晚期胎儿体重高的孕妇中新诊断的LGDM发生率为13.64%。除了LGDM女性的剖宫产率显著更高外,她们与非GDM女性的产科和新生儿并发症具有可比性。